Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) Return on Equity (2016 - 2021)

Phio Pharmaceuticals' Return on Equity history spans 10 years, with the latest figure at 0.46% for Q3 2021.

  • For Q3 2021, Return on Equity rose 8.0% year-over-year to 0.46%; the TTM value through Sep 2021 reached 0.46%, up 8.0%, while the annual FY2020 figure was 0.94%, 2.0% down from the prior year.
  • Return on Equity reached 0.46% in Q3 2021 per PHIO's latest filing, down from 0.37% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.37% in Q2 2021 to a low of 7.69% in Q1 2018.
  • Average Return on Equity over 5 years is 1.81%, with a median of 0.96% recorded in 2018.
  • Peak YoY movement for Return on Equity: crashed -641bps in 2018, then soared 712bps in 2019.
  • A 5-year view of Return on Equity shows it stood at 4.73% in 2017, then soared by 80bps to 0.96% in 2018, then crashed by -40bps to 1.35% in 2019, then surged by 54bps to 0.62% in 2020, then rose by 25bps to 0.46% in 2021.
  • Per Business Quant, the three most recent readings for PHIO's Return on Equity are 0.46% (Q3 2021), 0.37% (Q2 2021), and 0.45% (Q1 2021).